Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alison Moore currently holds 993,000 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alison Moore has been a net seller of ALLO stock. They have purchased $0 and sold $9.8M worth of shares.
Alison Moore's most recent insider trade was on Feb 23, 2026, when they sold 993,000 shares at $0.00 per share.
Alison Moore serves as Executive at Allogene Therapeutics, Inc. (ALLO). They have executed 45 insider transactions totaling $9.8M over their tenure at the company.
Alison Moore holds the position of Executive at Allogene Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Alison Moore has shown a selling trading pattern, with $0 in total purchases and $9.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alison Moore was on Oct 6, 2020, when they sold $1.8M worth of ALLO shares. This transaction involved 44,574 shares at $40.00 per share.
Alison Moore currently owns 993,000 shares of Allogene Therapeutics, Inc. (ALLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alison Moore's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alison Moore has 45 Form 4 filings on record as an insider at Allogene Therapeutics, Inc..
Set alerts for Alison Moore and 40,000+ other insiders.